tert-Butyl (4-hydroxy-1-methylcyclohexyl)carbamate

Catalog No. :
ACFGLX854
CAS No. :
792913-83-8
Molecular Formula :
C12H23NO3
Molecular Weight :
229.32

IUPAC Name:tert-butyl (4-hydroxy-1-methylcyclohexyl)carbamate

tert-Butyl (4-hydroxy-1-methylcyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$134.00Login to see priceIn stockInquiry
250mg98%$179.00Login to see priceIn stockInquiry
1g98%$436.00Login to see priceIn stockInquiry
5g98%$1748.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-hydroxy-1-methylcyclohexyl)carbamate
IUPAC Nametert-butyl (4-hydroxy-1-methylcyclohexyl)carbamate
MDL No.MFCD20040473
Molecular FormulaC12H23NO3
Molecular Weight229.32
SMILESO=C(OC(C)(C)C)NC1(C)CCC(O)CC1
InChI KeyJJAVBBNDEUQQSR-UHFFFAOYSA-N
SynonymMFCD23105964 | tert-Butyl (trans-4-hydroxy-1-methylcyclohexyl)carbamate | MFCD23105965 | AS-34691 | SB20632 | A849780 | tert-Butyl(4-hydroxy-1-methylcyclohexyl)carbamate | THIOPROPERAZINE [WHO-DD] | AS-51444 | NCGC00162068-05 | EN300-7171175 | P12690 | BR
CAS No.792913-83-8
PubChem CID45098094

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACFGLX854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPBQY918 route compound structure diagram
    ACPBQY918412293-43-7 In Stock
  2. Then
  3. ACFGLX854 route product structure diagram
    ACFGLX854792913-83-8 In Stock
Inquiry

2. ACFGLX854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFGLX854 route product structure diagram
    ACFGLX854792913-83-8 In Stock
Inquiry

Comments (0)